Table 2 Clinical outcomes 3 and 12 months after surgery for 42 patients with ankle fracture
AOFAS score—3 months (mean ± SD) | 72.8 ± 13.6 |
AOFAS score—12 months (mean ± SD) | 80.8 ± 13.1 |
FFI-DK score—3 months (mean ± SD) | 71.7 ± 48.1 |
FFI-DK score—12 months (mean ± SD) | 45.5 ± 46.9 |
EQ-5D-5L index score 3 months (mean ± SD) | 0.69 ± 0.13 |
EQ-5D-5L index score 12 months (mean ± SD) | 0.75 ± 0.16 |
Kellgren-Lawrence score—12 months | 1.5 ± 0.9 |
Joint space narrowing after–12 months (mm) | − 0.13 ± 0.48 |
VAS pain score—3 months at rest (mean ± SD) | 1.9 ± 1.8 |
VAS pain score—3 months on activity (mean ± SD) | 3.6 ± 2.6 |
VAS-score—12 months at rest (mean ± SD) | 1.0 ± 1.4 |
VAS-score—12 months on activity (mean ± SD) | 2.5 ± 2.4 |
Ankle swelling—3 months from surgery (mean ± SD) (cm) | 2.2 ± 1.3 |
Ankle swelling—12 months from surgery (mean ± SD) (cm) | 1.2 ± 1.0 |
Returned to work—3 months from surgery (yes/no) | (67.7%/32.5%) |
Returned to work—12 months from surgery (yes/no) | (83.3%/16.7%) |
Mobilization after 3 months | |
1: Still need assistive devices | 15.0% |
2: Can walk without assistive devices | 7.5% |
3: Can walk more than 500 m without assistive devices | 70.0% |
4: Returned to normal mobilization | 7.5% |
Mobilization after 12 months | |
1: Still need assistive devices | 0.0% |
2: Can walk without assistive devices | 0.0% |
3: Can walk more than 500 m without assistive devices | 56.1% |
4: Returned to normal mobilization | 43.9% |